Skip to content
Screener

PP&E (Net) at other companies

Amgen logo
AmgenAMGN
$8.55B+24.7%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$5.46B
Aclaris Therapeutics logo
Aclaris TherapeuticsACRS
$664K-23.5%
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
$4.51M-43.2%
Savara logo
SavaraSVRA
$641K+439%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$1.28M-26.5%

Other financials

Income statement

See full
Revenue$773.0K-17.5%
Operating income-$42.4M+4.5%
Net income-$39.7M+0.7%
EPS (diluted)-$0.73+1.4%

Balance sheet

See full
Cash & equivalents$79.4M+74.7%
Total debt$954.0K-38.9%
Total equity$271.0M-33.7%
Total assets$281.2M-33.1%

Cash flow

See full
Operating cash flow-$35.6M+9.2%
CapEx$54.0K-70.8%
Free cash flow-$30.7M-55.0%

Valuation

See full
Market cap$394.54M-54.7%
Enterprise value$316.1M-61.6%
P/S124.9×-195×

Profitability

See full
Operating margin-5,382.6%+1,393pp
Net margin-4,955.7%+2,041pp

Returns & leverage

See full
Return on equity-46%
Debt / equity0.0×
Current ratio28×-10.3×

Where this comes from

Reported directly by Upstream Bio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.

The source filing: Upstream Bio, Inc.’s 10-Q, filed August 11, 2026.

Filed
Aug 11, 2026, 7:10 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-343417
Line itemJune 30, 2026December 31, 2025
Accounts receivable772668
Prepaid expenses and other current assets17,5239,620
Total current assets279,602351,797
Property and equipment, net460559
Operating lease right-of-use assets9151,222
Restricted cash194194
Total assets$281,171$353,772
Liabilities and Stockholders’ Equity

Item 1. Financial Statements.

FAQ

What is Upstream Bio, Inc.'s PP&E (net)?
Upstream Bio, Inc. (UPB) reported PP&E (net) of $460K in Q2 2026.
How has Upstream Bio, Inc.'s PP&E (net) changed year-over-year?
Upstream Bio, Inc.'s PP&E (net) decreased by 15.4% year-over-year, from $544K to $460K.
What is the long-term trend for Upstream Bio, Inc.'s PP&E (net)?
Over 2 years (2023 to 2025), Upstream Bio, Inc.'s PP&E (net) has grown at a 87.5% compound annual growth rate (CAGR), from $159K to $559K.
What does PP&E (net) mean?
Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.

Ask your AI about Upstream Bio, Inc.'s pp&e (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude